NASDAQ:VRPX   Virpax Pharmaceuticals, Inc.
One more COVID idea, could just grab some commons and wait to see if there is any merit to their Antiviral nasal spray. In on some commons at $4.40, will wait a few weeks to see if this catches any strength
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。